Lucia Tombolan

Vicenza, 36100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors.

Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors.

Journal: International journal of molecular sciences

Published: August 19, 2025

Massive Bone Marrow Infiltration by Disseminated Alveolar Rhabdomyosarcoma Mimicking Acute Leukemia.

Massive Bone Marrow Infiltration by Disseminated Alveolar Rhabdomyosarcoma Mimicking Acute Leukemia.

Journal: Journal of pediatric hematology/oncology

Published: June 06, 2024

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.

Journal: Pediatric blood & cancer

Published: May 08, 2024

A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features.

A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features.

Journal: Scientific reports

Published: November 16, 2022

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Journal: JCO precision oncology

Published: October 20, 2022

Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma.

Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma.

Journal: Molecular oncology

Published: October 14, 2021

Corrigendum to 'Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner' [Translational Oncology 13 (2020) 100846].

Corrigendum to 'Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner' [Translational Oncology 13 (2020) 100846].

Journal: Translational oncology

Published: January 24, 2021

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.

Journal: Frontiers in pediatrics

Published: January 12, 2021

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.

Journal: Frontiers in genetics

Published: September 14, 2020

Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared.

Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared.

Journal: Diagnostics (Basel, Switzerland)

Published: September 10, 2020

Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study.

Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study.

Journal: Frontiers in oncology

Published: August 31, 2020

Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.

Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.

Journal: Translational oncology

Published: June 19, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026